ARWRNasdaqPharmaceutical PreparationsFiscal year ends September 30
ARROWHEAD PHARMACEUTICALS, INC.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$57.23+1.33 (+2.38%)
Close on Oct 19, 2026
- Market cap
- $8.21B
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$829.45MFY2025, +76.3% a year since FY2011